HCA Healthcare Gestione

Gestione criteri di controllo 2/4

HCA Healthcare Il CEO è Sam Hazen, nominato in Jan2019, e ha un mandato di 5.83 anni. la retribuzione annua totale è $ 21.32M, composta da 7.1% di stipendio e 92.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.52% delle azioni della società, per un valore di € 410.26M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.8 anni e 8.8 anni.

Informazioni chiave

Sam Hazen

Amministratore delegato

US$21.3m

Compenso totale

Percentuale dello stipendio del CEO	7.1%
Mandato del CEO	5.8yrs
Proprietà del CEO	0.5%
Durata media del management	5.8yrs
Durata media del Consiglio di amministrazione	8.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Sam Hazen rispetto agli utili di HCA Healthcare?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	US$6b
Jun 30 2024	n/a	n/a	US$6b
Mar 31 2024	n/a	n/a	US$5b
Dec 31 2023	US$21m	US$2m	US$5b
Sep 30 2023	n/a	n/a	US$6b
Jun 30 2023	n/a	n/a	US$6b
Mar 31 2023	n/a	n/a	US$6b
Dec 31 2022	US$15m	US$2m	US$6b
Sep 30 2022	n/a	n/a	US$5b
Jun 30 2022	n/a	n/a	US$7b
Mar 31 2022	n/a	n/a	US$7b
Dec 31 2021	US$21m	US$1m	US$7b
Sep 30 2021	n/a	n/a	US$7b
Jun 30 2021	n/a	n/a	US$5b
Mar 31 2021	n/a	n/a	US$5b
Dec 31 2020	US$30m	US$1m	US$4b
Sep 30 2020	n/a	n/a	US$3b
Jun 30 2020	n/a	n/a	US$3b
Mar 31 2020	n/a	n/a	US$3b
Dec 31 2019	US$27m	US$1m	US$4b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$10m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$3b
Jun 30 2018	n/a	n/a	US$3b
Mar 31 2018	n/a	n/a	US$3b
Dec 31 2017	US$10m	US$1m	US$2b

Compensazione vs Mercato: La retribuzione totale di Sam ($USD 21.32M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 4.74M ).

Compensazione vs guadagni: La retribuzione di Sam è aumentata di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Sam Hazen (64 yo)

5.8yrs

Mandato

US$21,315,984

Compensazione

Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Samuel Hazen	CEO & Director	5.8yrs	US$21.32m	0.52% € 410.3m
Jon Foster	Executive VP & COO	1.8yrs	US$8.70m	0.073% € 57.3m
Erol Akdamar	President of American Group	11.8yrs	US$5.40m	0.050% € 39.4m
Timothy McManus	President of National Group	8.3yrs	US$5.58m	0.011% € 8.4m
Thomas Frist	Founder & Chairman Emeritus	no data	US$362.11k	0.19% € 148.3m
Michael Marks	CFO & Executive Vice President	less than a year	Nessun dato	0.028% € 21.6m
Christopher Wyatt	Senior VP	8.6yrs	Nessun dato	0.016% € 12.5m
Chad Wasserman	Senior VP & Chief Information Officer	less than a year	Nessun dato	0.00062% € 486.2k
Michael McAlevey	Executive VP and Chief Legal & Administrative Officer	2.8yrs	US$6.47m	0.0016% € 1.2m
Frank Morgan	Vice President of Investor Relations	2.8yrs	Nessun dato	Nessun dato
Kathleen Whalen	Senior VP and Chief Ethics & Compliance Officer	5.8yrs	Nessun dato	0.0037% € 2.9m
Deborah Reiner	Senior Vice President of Marketing & Corporate Affairs	7.1yrs	Nessun dato	0.0014% € 1.1m

5.8yrs

Durata media

60yo

Età media

Gestione esperta: Il team dirigenziale di 2BH è esperto e expertise (durata media dell'incarico 5.8 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Samuel Hazen	CEO & Director	6.2yrs	US$21.32m	0.52% € 410.3m
Thomas Frist	Founder & Chairman Emeritus	no data	US$362.11k	0.19% € 148.3m
Michael Michelson	Independent Director	6.8yrs	US$389.78k	0% € 0
Robert Dennis	Independent Director	10.8yrs	US$377.95k	0.0016% € 1.3m
Nancy-Ann DeParle	Independent Director	10.8yrs	US$334.78k	0.0080% € 6.2m
Thomas Frist	Chairman of the Board	18.8yrs	US$399.61k	Nessun dato
Meg Crofton	Independent Director	5.7yrs	US$319.78k	0.0025% € 2.0m
Hugh Johnston	Independent Director	3.2yrs	US$339.78k	0.0010% € 815.6k
Wayne Riley	Independent Director	12.8yrs	US$349.78k	0.0043% € 3.3m
William Frist	Director	15.8yrs	US$309.70k	0.16% € 125.6m
Andrea Smith	Independent Director	2.8yrs	US$324.78k	0.0014% € 1.1m
John McWilliams	Director of HealthONE	no data	Nessun dato	Nessun dato

8.8yrs

Durata media

65yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 2BH sono considerati esperti (durata media dell'incarico 8.8 anni).

HCA Healthcare Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insufficient new directors

Insider recently sold €1.1m worth of stock

Insider recently sold €1.9m worth of stock

HCA Healthcare, Inc. Announces Executive Changes

HCA Healthcare, Inc. Announces Management Changes

HCA Healthcare, Inc. Announces Executive Changes

Recent updates

Third quarter dividend of US$0.66 announced

Third quarter 2024 earnings released: EPS: US$4.89 (vs US$3.98 in 3Q 2023)

Insufficient new directors

Upcoming dividend of US$0.66 per share

HCA Healthcare, Inc. (NYSE:HCA) acquired Emcare Holdings Inc. from Envision Healthcare Corporation.

Insider recently sold €1.1m worth of stock

Second quarter dividend of US$0.66 announced

Second quarter 2024 earnings released: EPS: US$5.53 (vs US$4.35 in 2Q 2023)

HCA Healthcare, Inc. Declares Quarterly Cash Dividend, Payable on September 30, 2024

Upcoming dividend of US$0.66 per share

Insider recently sold €1.9m worth of stock

First quarter dividend of US$0.66 announced

HCA Healthcare, Inc. Declares Quarterly Cash Dividend, Payable on June 28, 2024

First quarter 2024 earnings released: EPS: US$5.94 (vs US$4.92 in 1Q 2023)

Bright Start College Savings Trust Files a Notice of Exempt Solicitation to HCA Healthcare

HCA Healthcare, Inc. Announces Executive Changes

Upcoming dividend of US$0.66 per share

HCA Healthcare’s Sarah Cannon Cancer Institute Implements New Outpatient Model for CAR T-cell Therapy

HCA Healthcare, Inc. Announces Management Changes

HCA Healthcare, Inc. Announces Executive Changes

Insider recently sold €1.1m worth of stock

Fourth quarter dividend of US$0.66 announced

HCA Healthcare, Inc., Annual General Meeting, Apr 25, 2024

Full year 2023 earnings released: EPS: US$18.96 (vs US$19.44 in FY 2022)

HCA Healthcare, Inc. (NYSE:HCA) announces an Equity Buyback for $6,000 million worth of its shares.

Upcoming dividend of US$0.60 per share at 1.0% yield

Third quarter 2023 earnings released: EPS: US$3.92 (vs US$3.97 in 3Q 2022)

HCA Healthcare, Inc. Declares A Quarterly Cash Dividend, Payable on December 28, 2023

HCA Healthcare Research Institute Announces First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare's Johnston-Willis Hospital

Upcoming dividend of US$0.60 per share at 0.9% yield

Insider recently sold €1.3m worth of stock

HCA Healthcare, Inc. Declares Quarterly Dividend, Payable on September 29, 2023

Second quarter 2023 earnings released: EPS: US$4.29 (vs US$3.95 in 2Q 2022)

Upcoming dividend of US$0.60 per share at 0.9% yield

HCA Healthcare, Inc. (NYSE:HCA) agreed to acquire 41 urgent care centers in Texas from FastMed Urgent Care, P.C.

Insider recently sold €1.2m worth of stock

First quarter 2023 earnings released: EPS: US$4.85 (vs US$4.21 in 1Q 2022)

Upcoming dividend of US$0.60 per share at 1.0% yield

Insider recently sold €429k worth of stock

Insider recently sold €1.8m worth of stock

HCA Healthcare, Inc. Announces the Appointment of Jon M. Foster as the Executive Vice President and Chief Operating Officer

HCA Healthcare, Inc., Annual General Meeting, Apr 19, 2023

Full year 2022 earnings released: EPS: US$19.15 (vs US$21.52 in FY 2021)

HCA Healthcare, Inc.’s Innovative Approach to Surgical Recovery Promotes Better Outcomes, Decreased Opioid Usage and Faster Recovery Times for Patients

Upcoming dividend of US$0.56 per share

Insider recently sold €2.2m worth of stock

Insider recently sold €2.9m worth of stock

Insider recently sold €411k worth of stock

HCA Healthcare, Inc Announces Executive Changes

HCA Healthcare, Inc. Provides Guidance for the Full Year 2022

Third quarter 2022 earnings released: EPS: US$3.91 (vs US$7.13 in 3Q 2021)

HCA Healthcare, Inc. Declares Quarterly Cash Dividend , Payable on December 28, 2022

Louisiana Childrens Medical Center, Inc. agreed to acquire Tulane Medical Center/Lakeview Regional Medical Center/Tulane Lakeside Hospital from HCA Healthcare, Inc. (NYSE:HCA).

HCA Healthcare, Inc. Announces Retirement of Bruce Moore, President – Service Line and Operations Integration

Upcoming dividend of US$0.56 per share

HCA Healthcare, Inc. Announces Retirement of Longtime Senior Executive Chuck Hall

Insider recently bought €63k worth of stock

Investor sentiment improved over the past week

Insider recently bought €63k worth of stock

Second quarter 2022 earnings released: EPS: US$3.90 (vs US$4.42 in 2Q 2021)

HCA Healthcare, Inc. Declares Quarterly Cash Dividend, Payable on September 30, 2022

Upcoming dividend of US$0.56 per share

Insider recently sold €496k worth of stock

HCA Healthcare, Inc. Appoints Keith Zimmerman as President of the Company’s Kansas City-Based Midamerica Division

Independent Director recently bought €235k worth of stock

First quarter 2022 earnings released: EPS: US$4.14 (vs US$4.21 in 1Q 2021)

HCA Healthcare Revises Earnings Guidance for the Year 2022

First quarter 2022 earnings released: EPS: US$4.14 (vs US$4.21 in 1Q 2021)

Upcoming dividend of US$0.56 per share